Literature DB >> 7911821

Profound atrophy of the bone marrow reflecting major histocompatibility complex class II-restricted destruction of stem cells by CD4+ cells.

J Sprent1, C D Surh, D Agus, M Hurd, S Sutton, W R Heath.   

Abstract

The effector functions of CD4+ cells in vivo are presumed to reflect a combination of lymphokine-mediated bystander reactions and direct cytotoxic T lymphocyte activity. To assess the relative importance of these two mechanisms, we studied the effects of transferring small doses of purified unprimed CD4+ cells to lightly irradiated (600 cGy) recipients expressing major histocompatibility complex class II (Ia) differences. Within the first week after transfer, the host marrow was rapidly repopulated with hemopoietic cells. Thereafter, however, the donor CD4+ cells caused massive destruction of hemopoietic cells, both in marrow and spleen. Marrow aplasia did not affect stromal cells and was prevented by coinjecting donor but not host bone marrow. The use of allotypic markers and fluorescence-activated cell sorter analysis indicated that the destructive effects of CD4+ cells were directed selectively to host Ia+ hemopoietic cells, including stem cells; donor hemopoietic cells and Ia- host T cells were spared. No evidence could be found that the ongoing destruction of host cells impaired the capacity of donor stem cells to repopulate marrow, spleen, or thymus. Moreover, CD4+ cells failed to destroy host-type hemopoietic cells from Ia-deficient mice. Tissue destruction by CD4+ cells thus did not seem to reflect a bystander reaction. We conclude that, under defined conditions, CD4+ cells can manifest extremely potent Ia-restricted CTL activity in vivo, probably through recognition of covert Ia expression on stem cells and/or their immediate progeny.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7911821      PMCID: PMC2191561          DOI: 10.1084/jem.180.1.307

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

1.  CD4+ T cell-mediated killing of MHC class II-positive antigen-presenting cells. I. Characterization of target cell recognition by in vivo or in vitro activated CD4+ killer T cells.

Authors:  P Erb; D Grogg; M Troxler; M Kennedy; M Fluri
Journal:  J Immunol       Date:  1990-02-01       Impact factor: 5.422

Review 2.  Cytolytic T lymphocytes.

Authors:  M Nabholz; H R MacDonald
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

3.  A monoclonal antibody discriminating between subsets of T and B cells.

Authors:  J Bruce; F W Symington; T J McKearn; J Sprent
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

4.  GVHR elicited by products of class I or class II loci of the MHC: analysis of the response of mouse T lymphocytes to products of class I and class II loci of the MHC in correlation with GVHR-induced mortality, medullary aplasia, and enteropathy.

Authors:  P F Piguet
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

5.  Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones.

Authors:  D J Cher; T R Mosmann
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

6.  The generation of antigen-specific, major histocompatibility complex-restricted cytotoxic T lymphocytes of the CD4+ phenotype. Enhancement by the cutaneous administration of interleukin 2.

Authors:  G E Hancock; Z A Cohn; G Kaplan
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

7.  The role of host T cell subsets in bone marrow rejection directed to isolated major histocompatibility complex class I versus class II differences of bm1 and bm12 mutant mice.

Authors:  D A Vallera; P A Taylor; J Sprent; B R Blazar
Journal:  Transplantation       Date:  1994-01       Impact factor: 4.939

8.  Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. II. Protective effects of L3T4+ cells in anti-class II GVHD.

Authors:  J Sprent; M Schaefer; R Korngold
Journal:  J Immunol       Date:  1990-04-15       Impact factor: 5.422

9.  Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease.

Authors:  P F Piguet; G E Grau; B Allet; P Vassalli
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

10.  Properties of purified T cell subsets. I. In vitro responses to class I vs. class II H-2 alloantigens.

Authors:  J Sprent; M Schaefer
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

View more
  8 in total

Review 1.  Immune pathophysiology of aplastic anemia.

Authors:  Shinji Nakao; Xingmin Feng; Chiharu Sugimori
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

2.  Allogeneic T cells impair engraftment and hematopoiesis after stem cell transplantation.

Authors:  Antonia M S Müller; Jessica A Linderman; Mareike Florek; David Miklos; Judith A Shizuru
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

3.  Peroxisome proliferator-activated receptor gamma is required for CD4+ T cell-mediated lymphopenia-associated autoimmunity.

Authors:  William J Housley; Catherine O Adams; Amanda G Vang; Stefan Brocke; Frank C Nichols; Melissa LaCombe; Thiruchandurai V Rajan; Robert B Clark
Journal:  J Immunol       Date:  2011-09-09       Impact factor: 5.422

4.  Allogeneic Th1 cells home to host bone marrow and spleen and mediate IFNγ-dependent aplasia.

Authors:  Joseph H Chewning; Weiwei Zhang; David A Randolph; C Scott Swindle; Trenton R Schoeb; Casey T Weaver
Journal:  Biol Blood Marrow Transplant       Date:  2013-03-21       Impact factor: 5.742

5.  Identification of two epitopes on the dengue 4 virus capsid protein recognized by a serotype-specific and a panel of serotype-cross-reactive human CD4+ cytotoxic T-lymphocyte clones.

Authors:  S J Gagnon; W Zeng; I Kurane; F A Ennis
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

6.  CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses.

Authors:  B R Blazar; P A Taylor; R J Noelle; D A Vallera
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

7.  Aplastic anemia rescued by exhaustion of cytokine-secreting CD8+ T cells in persistent infection with lymphocytic choriomeningitis virus.

Authors:  D Binder; M F van den Broek; D Kägi; H Bluethmann; J Fehr; H Hengartner; R M Zinkernagel
Journal:  J Exp Med       Date:  1998-06-01       Impact factor: 14.307

8.  Retrovirus-specificity of regulatory T cells is neither present nor required in preventing retrovirus-induced bone marrow immune pathology.

Authors:  Inês Antunes; Mauro Tolaini; Adrien Kissenpfennig; Michihiro Iwashiro; Kagemasa Kuribayashi; Bernard Malissen; Kim Hasenkrug; George Kassiotis
Journal:  Immunity       Date:  2008-11-14       Impact factor: 31.745

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.